Lilly, Zydus Cadila Launch R&D Pact | April 6, 2009 Issue - Vol. 87 Issue 14 | Chemical & Engineering News
Volume 87 Issue 14 | p. 17 | Concentrates
Issue Date: April 6, 2009

Lilly, Zydus Cadila Launch R&D Pact

Department: Business

Zydus Cadila and Eli Lilly & Co. will collaborate to discover drugs in a program lasting up to six years. Lilly will provide Zydus with a new cardiovascular disease target. In turn, Zydus will conduct initial drug discovery work, lead identification and optimization, and preclinical studies and clinical trials up to Phase II. Lilly has rights to license any of the resulting molecules. It will pay Zydus as much as $300 million in milestones and royalties if a product is successfully launched. Lilly has similar agreements with Shanghai's Hutchison MediPharma and India's Piramal Healthcare.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment